(Total Views: 349)
Posted On: 09/04/2019 10:51:19 AM
Post# of 154812
Good logical point/s.
Seems the 8 pre-clinical trials were talked about a lot and even after RP's departure NP stated that Dr. Lindner at Cleveland Clinic would be conducting these trials. Since then only colon IND and TNBC injection and cancer hasn't been discussed much. It does make sense to pursue pre-clinical test to get phase 2s for NASH and other CCR5-linked indications if/as financing allows rather than 6.5 other metastatic cancers (gave TNBC half point for the breast cancer).
I'm not sure what data they have for MS. I think misiu mentioned they did some trials or test previously and it used to be noted in the footnotes of their PRs, but I searched today's and it wasn't noted....only says "multiple therapeutic indications"
Seems the 8 pre-clinical trials were talked about a lot and even after RP's departure NP stated that Dr. Lindner at Cleveland Clinic would be conducting these trials. Since then only colon IND and TNBC injection and cancer hasn't been discussed much. It does make sense to pursue pre-clinical test to get phase 2s for NASH and other CCR5-linked indications if/as financing allows rather than 6.5 other metastatic cancers (gave TNBC half point for the breast cancer).
I'm not sure what data they have for MS. I think misiu mentioned they did some trials or test previously and it used to be noted in the footnotes of their PRs, but I searched today's and it wasn't noted....only says "multiple therapeutic indications"
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
